Proteomics International continues to market PromarkerD in major global markets. Dr Richard Lipscombe presented PromarkerD to key bio-analytical sector decision makers at invitation only events in Boston (7th March), San Francisco (9th March) and San Diego (10th March), in the USA. The focus of the presentation was a case study on the benefit of biomarkers in the pharmaceutical development process.
